Book Value per Share: Protara Therapeutics (TARA)

Public company logo of Protara Therapeutics Inc (TARA)

Protara Therapeutics (TARA) focuses on implementing breakthrough therapies for rare oncological diseases, advancing the drug TARA-002 for the treatment of bladder and lymphatic pathologies. This price action chart featuring the 2.72 indicator demonstrates a company asset whose growth remains independent of global crises due to stable demand for healthcare. A high barrier to entry is driven by strict FDA oversight and the complexity of patenting cellular technologies.

Protara Therapeutics Inc (TARA) - Accounting Value per Share from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for protaratx.com (TARA)

- price and consensus price forecast:
Price Chart Protara|TARA - Fair Value Consensus
- market capitalization data:
Market Capitalization Protara Therapeutics, Inc.|TARA - Enterprise Value
- book capitalization data:
Book Value per Share Protara Therapeutics|TARA - Company Net Assets|Market Capitalization to Book Value Ratio protaratx.com|TARA - Company Total Assets
- debt and liquidity data:
Debt to Equity Protara Therapeutics|TARA - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Protara Therapeutics, Inc.|TARA - Company Total Debt|Debts to Book Capitalization Protara Therapeutics, Inc.
Analysis of all company metrics:Protara, TARA
Manufactured product of protaratx.com

Protara Therapeutics focuses on developing innovative targeted therapies to combat non-muscle invasive bladder cancer within the orphan drug segment. The book value per share, calculated as the difference between total assets and liabilities divided by the number of shares, reflects the actual value of capital, allowing the book value per share chart to assess resource utilization efficiency during the clinical trial period.

Competitor analysis for Protara Therapeutics

Net Assets per Single Share BeiGene Corp (ONC)|HALO - Accounting Value of a Share|RVMD: Book Value per Share|ascentage.com (AAPG) - Book Value per Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Fate Therapeutics Corp - Book Value per Share|WHWK - Accounting Value per Share|TScan - Accounting Value per Share|CSBR: Book Value per Share|Net Assets per Single Share xbiotech.com XBIT|CEL-SCI (CVM) - Accounting Value of a Share|Book Value per Share OSTX (OS Therapies Inc)|Net Asset Value per Share RADX|ARTV - Net Assets per Single Share|Share Book Value ANL (adlainortye.com)|Net Assets per Single Share Veru|Tempest Therapeutics Inc - Accounting Value of a Share|XLO (Xilio) - Net Assets per Single Share|Renovaro Inc. (RENB) - Net Asset Value per Share|MURA - Accounting Value per Share|Kairos Pharma (KAPA) - Book Price of a Share|OKUR (OnKure Therapeutics, Inc.) - Book Value per Share|Book Value per Share GDTC|Curis, Inc. (CRIS) - Net Assets per Single Share|Accounting Value of a Share apollomicsinc.com (APLM)|Book Value per Share THAR (Tharimmune, Inc.)|ADVB - Book Value per Share|Accounting Value per Share Genprex (GNPX)|Calidi Biotherapeutics (CLDI) - Accounting Value of a Share|SBFM - Accounting Value per Share|Xenetic Biosciences, Inc. (XBIO) - Book Price of a Share|SLRX - Book Value per Share|Accounting Value of a Share purple-biotech.com|American Oncology Network - Book Value per Share|Net Asset Value per Share BGNE (BeiGene Ltd.)|Net Assets per Single Share Checkpoint Therapeutics, Inc|Accounting Value of a Share elevationoncology.com ELEV|iCAD Corp - Book Value per Share|IKNA: Book Value per Share|Net Assets per Single Share Notable Labs (NTBL)|Viracta Therapeutics, Inc. (VIRX) - Share Book Value|Book Value per Share MOR (MorphoSys Corp)|Net Asset Value per Share NAYA Biosciences Corp (NAYA)|Accounting Value per Share AAPGV